Brookline Capital Acquisition Corp., established in New York in 2020, currently maintains no active business operations. Instead, its primary objective is to complete a strategic business combination, such as a merger, asset acquisition, or stock purchase, with an existing company. The company specifically targets opportunities within the life sciences industry.